Skip to main content

Table 5 Shows sub-group analysis of each scale in Stages 2 & 3 according to participants assessed while ON and OFF medication

From: Correlation between community balance and mobility scale (CB&M) with a battery of outcome measures to assess balance in Parkinson’s disease – a cross-sectional study

 

ON

Medication

 

OFF Medication

 

Mean (SD)

95% CI

Mean (SD)

95% CI

CB&M Stage 2

46.13 (28.87)

34.47–57.78

46.60 (19.97)

37.25–55.95

CB&M Stage 3

20.00 (12.27)

0.47–39.53

14.43 (8.40)

6.66–22.20

BBS Stage 2

45.38 (11.15)

39.43–51.32

46.45 (8.50)

42.47–50.43

BBS Stage 3

35.25 (11.41)

17.09–53.41

29.86 (10.07)

20.54–39.17

TUG Stage 2

11.24 (3.22)

9.52–12.96

12.96 (5.16)

10.54–15.38

TUG Stage 3

15.77 (4.46)

8.66–22.87

22.59 (7.01)

16.11–29.08

FRT Stage 2

22.25 (6.40)

18.84–25.66

20.90 (6.38)

17.91–23.89

FRT Stage 3

16.00 (7.57)

3.95–28.05

12.43 (4.07)

8.66–16.20